However, defects in tumor antigen processing and presentation functions, such as deficiency of MHC class I molecules, stands as a primary mechanism through which tumors avoid immune detection and evade eradication by CD8+ cytotoxic T cells [138]. This evidence concerns the gene CD8A and neoplasm.